EphA2/EphrinA1 mRNA Expression and Protein Production in Adenoid Cystic Carcinoma of Salivary Gland

被引:21
作者
Shao, Zhe [1 ,2 ,3 ]
Zhu, Fei [1 ,2 ]
Song, Kai [1 ,2 ]
Zhang, HanZhong [1 ,2 ]
Liu, Ke [1 ,2 ,3 ]
Shang, ZhengJun [1 ,2 ,3 ]
机构
[1] State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan, Peoples R China
[2] Minist Educ, Key Lab Oral Biomed, Wuhan, Peoples R China
[3] Wuhan Univ, Sch & Hosp Stomatol, Dept Oral & Maxillofacial & Head & Neck Oncol, Wuhan 430079, Peoples R China
基金
中国国家自然科学基金;
关键词
RECEPTOR TYROSINE KINASE; SQUAMOUS-CELL CARCINOMA; EPHA2; RECEPTOR; TUMOR ANGIOGENESIS; POOR-PROGNOSIS; CANCER; OVEREXPRESSION; SURVIVAL; BEHAVIOR; FEATURES;
D O I
10.1016/j.joms.2012.10.026
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Purpose: EphA2/ephrinA1 is believed to play a role in tumor growth and metastasis. The purpose of the present study was to determine the presence of EphA2/ephrinA1 in mRNA and protein adenoid cystic carcinoma. Materials and Methods: mRNA and protein expression and protein product of EphA2 and ephrinA1 in adenoid cystic carcinoma was investigated using real-time reverse transcriptase polymerase chain reaction, Western blot, and immunohistochemistry. The tyrosine-phosphorylated state of EphA2 in adenoid cystic carcinoma cells was also investigated. Results: Greater expression of EphA2 and ephrinA1 proteins and mRNA was detected in adenoid cystic carcinoma tissues. EphA2/ephrinA1 staining activities in adenoid cystic carcinoma were more significant than those in normal gland tissue (P < .01). EphA2/ephrinA1 expression correlated significantly to the microvessel density (P < .01). EphA2/ephrinA1 expression and microvessel density correlated with the clinical TNM stage, perineural invasion, and vascular invasion (P < .05). In 3 histologic types of adenoid cystic carcinoma, the expression of EphA2/ephrinA1 and microvessel density was significantly greater in the solid type than in the cribriform and tubular types (P < .01). We also noted that EphA2 was present in a nontyrosine-phosphorylated state. Conclusions: The present study showed a high expression of EphA2/ephrinA1 in adenoid cystic carcinoma. EphA2/ephrinA1 can serve as a novel therapy target for adenoid cystic carcinoma. (C) 2013 American Association of Oral and Maxillofacial Surgeons J Oral Maxillofac Surg 71:869-878, 2013
引用
收藏
页码:869 / 878
页数:10
相关论文
共 33 条
[1]   Expression of EphA2 and ephrin A-1 in carcinoma of the urinary bladder [J].
Abraham, S ;
Knapp, DW ;
Cheng, L ;
Snyder, PW ;
Mittal, SK ;
Bangari, DS ;
Kinch, M ;
Wu, L ;
Dhariwal, J ;
Mohammed, SI .
CLINICAL CANCER RESEARCH, 2006, 12 (02) :353-360
[2]   Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo [J].
Brantley, DM ;
Cheng, N ;
Thompson, EJ ;
Lin, Q ;
Brekken, RA ;
Thorpe, PE ;
Muraoka, RS ;
Cerretti, DP ;
Pozzi, A ;
Jackson, D ;
Lin, C ;
Chen, J .
ONCOGENE, 2002, 21 (46) :7011-7026
[3]   Eph receptor tyrosine kinases in tumor and tumor microenvironment [J].
Brantley-Sieders, D ;
Schmidt, S ;
Parker, M ;
Chen, J .
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (27) :3431-3442
[4]  
Carles-Kinch K, 2002, CANCER RES, V62, P2840
[5]   The brain within the tumor:: new roles for axon guidance molecules in cancers [J].
Chédotal, A ;
Kerjan, G ;
Moreau-Fauvarque, C .
CELL DEATH AND DIFFERENTIATION, 2005, 12 (08) :1044-1056
[6]   Antiangiogenic and antitumor efficacy of EphA2 receptor antagonist [J].
Dobrzanski, P ;
Hunter, K ;
Jones-Bolin, S ;
Chang, H ;
Robinson, C ;
Pritchard, S ;
Zhao, H ;
Ruggeri, B .
CANCER RESEARCH, 2004, 64 (03) :910-919
[7]   Ligation of EphA2 by Ephrin A1-Fc inhibits pancreatic adenocarcinoma cellular invasiveness [J].
Duxbury, MS ;
Ito, H ;
Zinner, MJ ;
Ashley, SW ;
Whang, EE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 320 (04) :1096-1102
[8]   The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas [J].
Han, LQ ;
Dong, ZM ;
Qiao, YH ;
Kristensen, GB ;
Holm, R ;
Nesland, JM ;
Suo, ZH .
GYNECOLOGIC ONCOLOGY, 2005, 99 (02) :278-286
[9]   Factors influencing survival rate in adenoid cystic carcinoma of the salivary glands [J].
Huang, MX ;
Ma, DQ ;
Sun, KH ;
Yu, GY ;
Guo, CB ;
Gao, F .
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 1997, 26 (06) :435-439
[10]   EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics [J].
Ireton, RC ;
Chen, J .
CURRENT CANCER DRUG TARGETS, 2005, 5 (03) :149-157